ATAI - ATAI Life Sciences GAAP EPS of -$0.21 in-line revenue of $0.04M
2023-05-11 09:23:10 ET
- ATAI Life Sciences press release ( NASDAQ: ATAI ): Q1 GAAP EPS of -$0.21 in-line.
- Revenue of $0.04M.
- Cash and cash equivalents and short-term investments totaled $249.9 million as of March 31, 2023, compared to $273.1 million of December 31, 2022.
For further details see:
ATAI Life Sciences GAAP EPS of -$0.21 in-line, revenue of $0.04M